Skip to main content
Year archive

XTL Biopharmaceuticals Ltd. — 2023 filings

All 33 regulatory filings released by XTL Biopharmaceuticals Ltd. (XTLB) in 2023, sourced directly from the official regulator.

33 Filings
2023 Period
2023 filings (33)
Filing Released Lang
Form 6-K- financial results for the nine months ended September 30, 2023
Interim / Quarterly Report 9M 2023
2023-11-15 English
Form 6-K- financial results for the nine months ended September 30, 2023
Report Publication Announcement FY 2023
2023-11-15 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-11-15 English
6K-Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency; Confirms that it has not Experienced any Disruption to its Business Operations in Israel
Regulatory Filings
2023-10-20 English
6K-Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency; Confirms that it has not Experienced any Disruption to its Business Operations in Israel
Report Publication Announcement
2023-10-20 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-10-20 English
Financial results for the six months ended June 30, 2023
Interim / Quarterly Report H1 2023
2023-08-10 English
Financial results for the six months ended June 30, 2023
Report Publication Announcement
2023-08-10 English
XTL-financial results for the six months ended June 30, 2023
Interim / Quarterly Report H1 2023
2023-08-10 English
XTL-financial results for the six months ended June 30, 2023
Report Publication Announcement
2023-08-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-08-10 English
Financial Overview for Three Months Ended March 31, 2023
Interim / Quarterly Report Q1 2023
2023-05-16 English
Financial Overview for Three Months Ended March 31, 2023
Report Publication Announcement FY 2022
2023-05-16 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-05-16 English
Year ended December 31 ,2022 Results
Annual Report FY 2022
2023-03-22 English
Year ended December 31 ,2022 Results
Report Publication Announcement
2023-03-22 English
ANNUAL REPORT
Annual Report FY 2022
2023-03-22 English
Results of Meeting held on March 2, 2023
Declaration of Voting Results & Voting Rights Announcements
2023-03-03 English
Results of Meeting held on March 2, 2023
Report Publication Announcement
2023-03-03 English
Results of Meeting held on March 2, 2023
Declaration of Voting Results & Voting Rights Announcements
2023-03-03 English
Results of Meeting held on March 2, 2023
Report Publication Announcement
2023-03-03 English
FORM 6-K
Foreign Filer Report
2023-03-02 English
deferred annual shareholders meeting will reconvene on March 02, 2023
AGM Information
2023-02-24 English
deferred annual shareholders meeting will reconvene on March 02, 2023
AGM Information
2023-02-24 English
FORM 6-K
Foreign Filer Report
2023-02-23 English
Immediate Report of Meeting to be held on February 23, 23-Scribal error
Proxy Solicitation & Information Statement
2023-02-01 English
Immediate Report of Meeting to be held on February 23, 23-Scribal error
AGM Information
2023-02-01 English
Immediate Report of Meeting to be held on February 23, 23-Scribal error
AGM Information
2023-02-01 English
AMENDMENT 1 TO FORM 6-K
Foreign Filer Report
2023-02-01 English
NOTICE OF 2022 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON FEBRUARY 23, 2023
AGM Information
2023-01-21 English
NOTICE OF 2022 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON FEBRUARY 23, 2023
AGM Information
2023-01-21 English
NOTICE OF 2022 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON FEBRUARY 23, 2023
AGM Information
2023-01-21 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-01-20 English